PRESS RELEASE published on 05/26/2026 at 22:00, 4 months 30 days ago Inventiva publie ses informations financières du premier trimestre 2026¹ Inventiva publie ses informations financières du premier trimestre 2026, montrant une trésorerie de 75 millions d'euros et des dépôts à court terme de 121,5 millions d'euros Trésorerie Inventiva Trimestre 2026 Dépôts À Court Terme Équivalents De Trésorerie
BRIEF published on 05/21/2026 at 22:05, 5 months 4 days ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva Lanifibranor MASH Treatment Jefferies Conference
BRIEF published on 05/21/2026 at 22:05, 5 months 4 days ago Inventiva à la 2026 Jefferies Global Healthcare Conference Biopharmaceutique Inventiva Conférence Jefferies MASH Lanifibranor
BRIEF published on 05/21/2026 at 22:05, 5 months 4 days ago Inventiva at the 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva MASH Lanifibranor Jefferies Conference
BRIEF published on 05/21/2026 at 22:05, 5 months 4 days ago Inventiva présentera ses travaux lors de la conférence mondiale Jefferies sur les soins de santé 2026. Biopharmaceutique Inventive Conférence Jefferies Lanifibranor Traitement MASH
PRESS RELEASE published on 05/21/2026 at 22:00, 5 months 4 days ago Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference à New York City son traitement oral pour la stéatohépatite. Détails de la présentation le 3 juin 2026 Inventiva Lanifibranor Stéatohépatite 2026 Jefferies Global Healthcare Conference Traitement Oral
PRESS RELEASE published on 05/21/2026 at 22:00, 5 months 4 days ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Inventiva to present at 2026 Jefferies Global Healthcare Conference in New York City. CEO Andrew Obenshain to speak on June 3, 2026, about MASH therapies Clinical-Stage Biopharmaceutical Inventiva Lanifibranor 2026 Jefferies Conference MASH Therapies
BRIEF published on 05/13/2026 at 08:35, 5 months 13 days ago Inventiva presents its research on lanifibranor at the EASL Congress 2026 Biopharmaceutical Inventiva MASH Lanifibranor EASL Congress 2026
BRIEF published on 05/13/2026 at 08:35, 5 months 13 days ago Inventiva to Present Abstracts at EASL Congress 2026 Biopharmaceutical Research Inventiva Lanifibranor MASH Treatment EASL Congress 2026
BRIEF published on 05/13/2026 at 08:35, 5 months 13 days ago Inventiva présentera des résumés au congrès EASL 2026 Recherche Biopharmaceutique Inventive Lanifibranor Traitement MASH Congrès EASL 2026
Published on 10/24/2026 at 00:04, 2 days 10 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 10 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 12 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 18 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/26/2026 at 10:05, 11 minutes ago Medline Celebrates 10 Years of Partnership with WRAP, Advancing Responsible Manufacturing
Published on 10/26/2026 at 10:00, 16 minutes ago Abu Dhabi Invests In The Next Generation Of Musical Talent With A New Dedicated Institution For The Youth Orchestra Abu Dhabi
Published on 10/26/2026 at 10:00, 16 minutes ago TalkTalk and Zattoo bring mobile and TV together: launch of the new Mobile’n Stream bundles
Published on 10/26/2026 at 09:55, 21 minutes ago Guosen Securities Outlines Priorities for China's Capital Markets Under 15th Five-Year Plan
Published on 10/26/2026 at 09:47, 29 minutes ago Rixos Hotels Egypt Announces New Year 2027 Entertainment Programme
Published on 10/26/2026 at 07:30, 2 hours 46 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/26/2026 at 07:30, 2 hours 46 minutes ago LE CONSEIL DE SURVEILLANCE D’EURAZEO NOMME M. CHRISTOPHE BAVIERE PRESIDENT DU DIRECTOIRE
Published on 10/23/2026 at 20:33, 2 days 13 hours ago Déclaration hebdomadaire d'opérations effectuées du 19 au 23 octobre 2026
Published on 10/23/2026 at 20:33, 2 days 13 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 16 hours ago Imerys-10-2026-communique-capital-droits-de-vote-au-30-septembre-2026
